S-26131
S-26131 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a selective antagonist of the 5-HT6 receptor, a subtype of the serotonin receptor family. This receptor is predominantly expressed in the central nervous system and is implicated in various neurological processes, including cognition and mood regulation.
Pharmacology[edit | edit source]
S-26131 acts as a selective antagonist at the 5-HT6 receptor. By blocking this receptor, S-26131 can influence neurotransmitter release and modulate neuronal activity. The 5-HT6 receptor is involved in the regulation of acetylcholine, dopamine, and glutamate release, which are critical neurotransmitters in cognitive processes.
Mechanism of Action[edit | edit source]
The mechanism by which S-26131 exerts its effects involves the inhibition of the 5-HT6 receptor, which is a G-protein coupled receptor (GPCR). This inhibition leads to alterations in intracellular signaling pathways, ultimately affecting neurotransmitter systems that are crucial for learning and memory.
Potential Therapeutic Applications[edit | edit source]
Research into S-26131 has suggested potential applications in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia. By modulating the activity of the 5-HT6 receptor, S-26131 may enhance cognitive function and ameliorate symptoms associated with these conditions.
Research and Development[edit | edit source]
Studies on S-26131 have primarily been conducted in preclinical settings. Animal models have been used to assess its efficacy and safety profile. These studies have shown promising results in terms of cognitive enhancement and neuroprotection.
Safety and Side Effects[edit | edit source]
As of the latest research, the safety profile of S-26131 is still under investigation. Common side effects observed in preclinical trials include mild gastrointestinal disturbances and transient changes in behavior. Further studies are required to fully understand the long-term safety and potential adverse effects in humans.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
